English
简体中文
Total: £ 56.28
Published Date: 2024-07-22 | Pages: 86 | Tables: 162 | Medical Care
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
The global Monkeypox Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Monkeypox Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Monkeypox Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Monkeypox Treatment in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Monkeypox Treatment include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd. and Mylan N.V., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monkeypox Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Treatment.
Report Scope
The Monkeypox Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monkeypox Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monkeypox Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Monkeypox Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Treatment Market Perspective (2019-2030)
2.2 Monkeypox Treatment Growth Trends by Region
2.2.1 Global Monkeypox Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monkeypox Treatment Historic Market Size by Region (2019-2024)
2.2.3 Monkeypox Treatment Forecasted Market Size by Region (2025-2030)
2.3 Monkeypox Treatment Market Dynamics
2.3.1 Monkeypox Treatment Industry Trends
2.3.2 Monkeypox Treatment Market Drivers
2.3.3 Monkeypox Treatment Market Challenges
2.3.4 Monkeypox Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Treatment Players by Revenue
3.1.1 Global Top Monkeypox Treatment Players by Revenue (2019-2024)
3.1.2 Global Monkeypox Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monkeypox Treatment Revenue
3.4 Global Monkeypox Treatment Market Concentration Ratio
3.4.1 Global Monkeypox Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Treatment Revenue in 2023
3.5 Monkeypox Treatment Key Players Head office and Area Served
3.6 Key Players Monkeypox Treatment Product Solution and Service
3.7 Date of Enter into Monkeypox Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Treatment Breakdown Data by Type
4.1 Global Monkeypox Treatment Historic Market Size by Type (2019-2024)
4.2 Global Monkeypox Treatment Forecasted Market Size by Type (2025-2030)
5 Monkeypox Treatment Breakdown Data by Application
5.1 Global Monkeypox Treatment Historic Market Size by Application (2019-2024)
5.2 Global Monkeypox Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monkeypox Treatment Market Size (2019-2030)
6.2 North America Monkeypox Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monkeypox Treatment Market Size by Country (2019-2024)
6.4 North America Monkeypox Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size (2019-2030)
7.2 Europe Monkeypox Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monkeypox Treatment Market Size by Country (2019-2024)
7.4 Europe Monkeypox Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Market Size (2019-2030)
8.2 Asia-Pacific Monkeypox Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monkeypox Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Monkeypox Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Treatment Market Size (2019-2030)
9.2 Latin America Monkeypox Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monkeypox Treatment Market Size by Country (2019-2024)
9.4 Latin America Monkeypox Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Market Size (2019-2030)
10.2 Middle East & Africa Monkeypox Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monkeypox Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Monkeypox Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Detail
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Monkeypox Treatment Introduction
11.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2019-2024)
11.1.5 Bavarian Nordic Recent Development
11.2 Chimerix, Inc.
11.2.1 Chimerix, Inc. Company Detail
11.2.2 Chimerix, Inc. Business Overview
11.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
11.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2019-2024)
11.2.5 Chimerix, Inc. Recent Development
11.3 CIDIC Company Limited
11.3.1 CIDIC Company Limited Company Detail
11.3.2 CIDIC Company Limited Business Overview
11.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
11.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2019-2024)
11.3.5 CIDIC Company Limited Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Detail
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2019-2024)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 Emergent
11.5.1 Emergent Company Detail
11.5.2 Emergent Business Overview
11.5.3 Emergent Monkeypox Treatment Introduction
11.5.4 Emergent Revenue in Monkeypox Treatment Business (2019-2024)
11.5.5 Emergent Recent Development
11.6 Gilead Sciences Inc.
11.6.1 Gilead Sciences Inc. Company Detail
11.6.2 Gilead Sciences Inc. Business Overview
11.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
11.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2019-2024)
11.6.5 Gilead Sciences Inc. Recent Development
11.7 Hetero Drugs Limited
11.7.1 Hetero Drugs Limited Company Detail
11.7.2 Hetero Drugs Limited Business Overview
11.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
11.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2019-2024)
11.7.5 Hetero Drugs Limited Recent Development
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Detail
11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2019-2024)
11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Detail
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Monkeypox Treatment Introduction
11.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2019-2024)
11.9.5 Mylan N.V. Recent Development
11.10 Olon S.p.A.
11.10.1 Olon S.p.A. Company Detail
11.10.2 Olon S.p.A. Business Overview
11.10.3 Olon S.p.A. Monkeypox Treatment Introduction
11.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2019-2024)
11.10.5 Olon S.p.A. Recent Development
11.11 Piramal Pharma Solutions
11.11.1 Piramal Pharma Solutions Company Detail
11.11.2 Piramal Pharma Solutions Business Overview
11.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
11.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2019-2024)
11.11.5 Piramal Pharma Solutions Recent Development
11.12 SIGA Technologies Inc.
11.12.1 SIGA Technologies Inc. Company Detail
11.12.2 SIGA Technologies Inc. Business Overview
11.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
11.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2019-2024)
11.12.5 SIGA Technologies Inc. Recent Development
11.13 Sonofi SA
11.13.1 Sonofi SA Company Detail
11.13.2 Sonofi SA Business Overview
11.13.3 Sonofi SA Monkeypox Treatment Introduction
11.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2019-2024)
11.13.5 Sonofi SA Recent Development
11.14 Teva Pharmaceutical Industries Limited
11.14.1 Teva Pharmaceutical Industries Limited Company Detail
11.14.2 Teva Pharmaceutical Industries Limited Business Overview
11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2019-2024)
11.14.5 Teva Pharmaceutical Industries Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monkeypox Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Monkeypox Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Monkeypox Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Monkeypox Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Monkeypox Treatment Market Share by Region (2019-2024)
Table 8. Global Monkeypox Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Monkeypox Treatment Market Share by Region (2025-2030)
Table 10. Monkeypox Treatment Market Trends
Table 11. Monkeypox Treatment Market Drivers
Table 12. Monkeypox Treatment Market Challenges
Table 13. Monkeypox Treatment Market Restraints
Table 14. Global Monkeypox Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Monkeypox Treatment Market Share by Players (2019-2024)
Table 16. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2023)
Table 17. Ranking of Global Top Monkeypox Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Monkeypox Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monkeypox Treatment Product Solution and Service
Table 21. Date of Enter into Monkeypox Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monkeypox Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Monkeypox Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Monkeypox Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Monkeypox Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Monkeypox Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Monkeypox Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Monkeypox Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Monkeypox Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Monkeypox Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Monkeypox Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Monkeypox Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Monkeypox Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Monkeypox Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Monkeypox Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Monkeypox Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Monkeypox Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Monkeypox Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Monkeypox Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Monkeypox Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bavarian Nordic Company Detail
Table 47. Bavarian Nordic Business Overview
Table 48. Bavarian Nordic Monkeypox Treatment Product
Table 49. Bavarian Nordic Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 50. Bavarian Nordic Recent Development
Table 51. Chimerix, Inc. Company Detail
Table 52. Chimerix, Inc. Business Overview
Table 53. Chimerix, Inc. Monkeypox Treatment Product
Table 54. Chimerix, Inc. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 55. Chimerix, Inc. Recent Development
Table 56. CIDIC Company Limited Company Detail
Table 57. CIDIC Company Limited Business Overview
Table 58. CIDIC Company Limited Monkeypox Treatment Product
Table 59. CIDIC Company Limited Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 60. CIDIC Company Limited Recent Development
Table 61. Emcure Pharmaceuticals Company Detail
Table 62. Emcure Pharmaceuticals Business Overview
Table 63. Emcure Pharmaceuticals Monkeypox Treatment Product
Table 64. Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 65. Emcure Pharmaceuticals Recent Development
Table 66. Emergent Company Detail
Table 67. Emergent Business Overview
Table 68. Emergent Monkeypox Treatment Product
Table 69. Emergent Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 70. Emergent Recent Development
Table 71. Gilead Sciences Inc. Company Detail
Table 72. Gilead Sciences Inc. Business Overview
Table 73. Gilead Sciences Inc. Monkeypox Treatment Product
Table 74. Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 75. Gilead Sciences Inc. Recent Development
Table 76. Hetero Drugs Limited Company Detail
Table 77. Hetero Drugs Limited Business Overview
Table 78. Hetero Drugs Limited Monkeypox Treatment Product
Table 79. Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 80. Hetero Drugs Limited Recent Development
Table 81. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Detail
Table 82. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
Table 83. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product
Table 84. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 85. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
Table 86. Mylan N.V. Company Detail
Table 87. Mylan N.V. Business Overview
Table 88. Mylan N.V. Monkeypox Treatment Product
Table 89. Mylan N.V. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 90. Mylan N.V. Recent Development
Table 91. Olon S.p.A. Company Detail
Table 92. Olon S.p.A. Business Overview
Table 93. Olon S.p.A. Monkeypox Treatment Product
Table 94. Olon S.p.A. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 95. Olon S.p.A. Recent Development
Table 96. Piramal Pharma Solutions Company Detail
Table 97. Piramal Pharma Solutions Business Overview
Table 98. Piramal Pharma Solutions Monkeypox Treatment Product
Table 99. Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 100. Piramal Pharma Solutions Recent Development
Table 101. SIGA Technologies Inc. Company Detail
Table 102. SIGA Technologies Inc. Business Overview
Table 103. SIGA Technologies Inc. Monkeypox Treatment Product
Table 104. SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 105. SIGA Technologies Inc. Recent Development
Table 106. Sonofi SA Company Detail
Table 107. Sonofi SA Business Overview
Table 108. Sonofi SA Monkeypox Treatment Product
Table 109. Sonofi SA Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 110. Sonofi SA Recent Development
Table 111. Teva Pharmaceutical Industries Limited Company Detail
Table 112. Teva Pharmaceutical Industries Limited Business Overview
Table 113. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product
Table 114. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2019-2024) & (US$ Million)
Table 115. Teva Pharmaceutical Industries Limited Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monkeypox Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Monkeypox Treatment Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Injectable Features
Figure 5. Global Monkeypox Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Monkeypox Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Monkeypox Treatment Report Years Considered
Figure 11. Global Monkeypox Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Monkeypox Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Monkeypox Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Monkeypox Treatment Market Share by Players in 2023
Figure 15. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Monkeypox Treatment Revenue in 2023
Figure 17. North America Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Monkeypox Treatment Market Share by Country (2019-2030)
Figure 19. United States Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Monkeypox Treatment Market Share by Country (2019-2030)
Figure 23. Germany Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Monkeypox Treatment Market Share by Region (2019-2030)
Figure 31. China Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Monkeypox Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Monkeypox Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Monkeypox Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bavarian Nordic Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 46. Chimerix, Inc. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 47. CIDIC Company Limited Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 48. Emcure Pharmaceuticals Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 49. Emergent Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 50. Gilead Sciences Inc. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 51. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 52. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 53. Mylan N.V. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 54. Olon S.p.A. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 55. Piramal Pharma Solutions Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 56. SIGA Technologies Inc. Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 57. Sonofi SA Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 58. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Treatment Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
